Impact of Smoking, Benzodiazepine (BZD) Use and Obesity on Severe Obstructive Sleep Apnea (sOSA)
NCT02539264 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 920
Last updated 2016-01-06
Summary
In this study the investigators will analyze the influence of smoking, benzodizepine use, and obesity among patients with severe Obstructive Sleep Apnea (sOSA).
Conditions
- Obstructive Sleep Apnea
- Obesity
- Smoking
Interventions
- OTHER
-
Smoking
Influence of smoking on parameters derived from overnight PSG
- OTHER
-
Influence of obesity on parameters derived from overnight PSG
- OTHER
-
Benzodiazepine use
Influence of benzodiazepine use on parameters derived from overnight PSG
Sponsors & Collaborators
-
Astes
lead OTHER
Principal Investigators
-
Eric DEFLANDRE, MD, FCCP · Astes
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-01-31
- Primary Completion
- 2015-06-30
- Completion
- 2015-07-31
More Related Trials
-
Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea
NCT00768625 ·Status: UNKNOWN
-
Lifestyle Modification Program to Treat Obstructive Sleep Apnea Patients
NCT01384760 ·Status: COMPLETED ·Phase: NA
-
Relationship Between Obstructive Sleep Apnea and Coronary Atherosclerosis
NCT01306526 ·Status: COMPLETED
-
Lifestyle Program for Obstructive Sleep Apnea With Severe Obesity
NCT05343000 ·Status: COMPLETED ·Phase: NA
-
Underlying Mechanisms of Obesity-induced Obstructive Sleep Apnea
NCT04793334 ·Status: COMPLETED
-
Relationship Between Normal-weight Central Obesity and Obstructive Sleep Apnea
NCT04061226 ·Status: COMPLETED
-
Effect of Nasal CPAP on Lipid Profile in Patients With Dyslipidaemia and Sleep Apnea
NCT02557412 ·Status: WITHDRAWN ·Phase: NA
-
Impact of Obstructive Sleep Apnea Treatment in Patients With Metabolic Syndrome
NCT02295202 ·Status: COMPLETED ·Phase: PHASE4
-
Accelerated Aging in Middle-Aged Men With Sleep-disordered Breathing.
NCT02876653 ·Status: COMPLETED ·Phase: NA
-
Impact of Obstructive Sleep Apnea Syndrome on Metabolic Syndrome in Severe Obesity
NCT01029561 ·Status: UNKNOWN ·Phase: NA
-
A Brief Lifestyle Modification Programme in Overweight Subjects With Obstructive Sleep Apnoea - Needs Assessment
NCT04262986 ·Status: UNKNOWN
-
Effects of Obstructive Sleep Apnea and/or Cigarette Smoking on Endothelial Function
NCT00957463 ·Status: COMPLETED
-
A Study to Investigate the Effects of Daridorexant on Nighttime Breathing in Patients With Shallow or Paused Breath During Sleep
NCT05458193 ·Status: COMPLETED ·Phase: PHASE1
-
BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.
NCT01072968 ·Status: COMPLETED ·Phase: PHASE3
-
Predictors of OSA in Patients With COPD
NCT05605431 ·Status: COMPLETED
-
Combination Pharmacological Interventions for Multiple Mechanisms of Obstructive Sleep Apnea
NCT03892772 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Asthma and Obstructive Sleep Apnea (OSA)
NCT01026298 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of an Intensive Weight Loss Program for Obstructive Sleep Apnea Syndrome (OSAS) Treatment.
NCT02832414 ·Status: COMPLETED ·Phase: NA
-
Sleep-disordered Breathing in Postmenopausal Women
NCT01825291 ·Status: COMPLETED
-
Precision OSA Therapy Based on Phenotypes and Endotypes
NCT06825923 ·Status: NOT_YET_RECRUITING
-
Obstructive Sleep Apnea and Biomarkers of Alzheimer's Disease
NCT04905238 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Mediterranean-type Diet for Older Adults With Obstructive Sleep Apnea
NCT03514199 ·Status: UNKNOWN ·Phase: NA
-
Pharmacological Intervention for Symptomatic Snoring
NCT03720353 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Continuous Positive Airway Pressure and Oral Appliances Treatments in Mild Obstructive Sleep Apnea
NCT01461486 ·Status: COMPLETED ·Phase: NA
-
Vascular Endothelial Dysfunction in Sleep Apnea
NCT05289063 ·Status: RECRUITING ·Phase: PHASE1